nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—CYP3A4—Vandetanib—thyroid cancer	0.0916	0.286	CbGbCtD
Bisoprolol—CYP2D6—Sorafenib—thyroid cancer	0.0868	0.272	CbGbCtD
Bisoprolol—CYP3A4—Sorafenib—thyroid cancer	0.0552	0.173	CbGbCtD
Bisoprolol—CYP2D6—Doxorubicin—thyroid cancer	0.0527	0.165	CbGbCtD
Bisoprolol—CYP3A4—Doxorubicin—thyroid cancer	0.0335	0.105	CbGbCtD
Bisoprolol—Dizziness—Vandetanib—thyroid cancer	0.00159	0.00234	CcSEcCtD
Bisoprolol—Thrombocytopenia—Sorafenib—thyroid cancer	0.00159	0.00233	CcSEcCtD
Bisoprolol—Skin disorder—Sorafenib—thyroid cancer	0.00158	0.00232	CcSEcCtD
Bisoprolol—Neck pain—Doxorubicin—thyroid cancer	0.00157	0.00231	CcSEcCtD
Bisoprolol—Abnormal dreams—Doxorubicin—thyroid cancer	0.00154	0.00226	CcSEcCtD
Bisoprolol—Coma—Epirubicin—thyroid cancer	0.00153	0.00226	CcSEcCtD
Bisoprolol—Vomiting—Vandetanib—thyroid cancer	0.00153	0.00225	CcSEcCtD
Bisoprolol—Bladder pain—Epirubicin—thyroid cancer	0.00152	0.00223	CcSEcCtD
Bisoprolol—Cystitis noninfective—Doxorubicin—thyroid cancer	0.00152	0.00223	CcSEcCtD
Bisoprolol—Rash—Vandetanib—thyroid cancer	0.00152	0.00223	CcSEcCtD
Bisoprolol—Dermatitis—Vandetanib—thyroid cancer	0.00151	0.00223	CcSEcCtD
Bisoprolol—Headache—Vandetanib—thyroid cancer	0.00151	0.00221	CcSEcCtD
Bisoprolol—Cystitis—Doxorubicin—thyroid cancer	0.0015	0.00221	CcSEcCtD
Bisoprolol—Pulmonary oedema—Epirubicin—thyroid cancer	0.0015	0.0022	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00148	0.00217	CcSEcCtD
Bisoprolol—Fluid retention—Doxorubicin—thyroid cancer	0.00148	0.00217	CcSEcCtD
Bisoprolol—Abnormal vision—Epirubicin—thyroid cancer	0.00147	0.00215	CcSEcCtD
Bisoprolol—Dyspnoea—Sorafenib—thyroid cancer	0.00145	0.00213	CcSEcCtD
Bisoprolol—Nausea—Vandetanib—thyroid cancer	0.00143	0.0021	CcSEcCtD
Bisoprolol—Dyspepsia—Sorafenib—thyroid cancer	0.00143	0.0021	CcSEcCtD
Bisoprolol—Coma—Doxorubicin—thyroid cancer	0.00142	0.00209	CcSEcCtD
Bisoprolol—Bladder pain—Doxorubicin—thyroid cancer	0.00141	0.00207	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.0014	0.00206	CcSEcCtD
Bisoprolol—Fatigue—Sorafenib—thyroid cancer	0.0014	0.00206	CcSEcCtD
Bisoprolol—Photosensitivity—Epirubicin—thyroid cancer	0.00139	0.00204	CcSEcCtD
Bisoprolol—Constipation—Sorafenib—thyroid cancer	0.00139	0.00204	CcSEcCtD
Bisoprolol—Pain—Sorafenib—thyroid cancer	0.00139	0.00204	CcSEcCtD
Bisoprolol—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00138	0.00203	CcSEcCtD
Bisoprolol—Vascular purpura—Epirubicin—thyroid cancer	0.00136	0.002	CcSEcCtD
Bisoprolol—Eczema—Epirubicin—thyroid cancer	0.00136	0.00199	CcSEcCtD
Bisoprolol—Abnormal vision—Doxorubicin—thyroid cancer	0.00136	0.00199	CcSEcCtD
Bisoprolol—Eye pain—Epirubicin—thyroid cancer	0.00135	0.00199	CcSEcCtD
Bisoprolol—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00134	0.00198	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00133	0.00195	CcSEcCtD
Bisoprolol—Hot flush—Epirubicin—thyroid cancer	0.0013	0.00192	CcSEcCtD
Bisoprolol—Menopausal symptoms—Epirubicin—thyroid cancer	0.00129	0.0019	CcSEcCtD
Bisoprolol—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.00129	0.0019	CcSEcCtD
Bisoprolol—Urticaria—Sorafenib—thyroid cancer	0.00129	0.00189	CcSEcCtD
Bisoprolol—Photosensitivity—Doxorubicin—thyroid cancer	0.00128	0.00189	CcSEcCtD
Bisoprolol—Body temperature increased—Sorafenib—thyroid cancer	0.00128	0.00188	CcSEcCtD
Bisoprolol—Abdominal pain—Sorafenib—thyroid cancer	0.00128	0.00188	CcSEcCtD
Bisoprolol—Purpura—Epirubicin—thyroid cancer	0.00127	0.00186	CcSEcCtD
Bisoprolol—Vascular purpura—Doxorubicin—thyroid cancer	0.00126	0.00185	CcSEcCtD
Bisoprolol—Eczema—Doxorubicin—thyroid cancer	0.00126	0.00185	CcSEcCtD
Bisoprolol—Eye pain—Doxorubicin—thyroid cancer	0.00125	0.00184	CcSEcCtD
Bisoprolol—Hypoglycaemia—Epirubicin—thyroid cancer	0.00125	0.00184	CcSEcCtD
Bisoprolol—Cardiac failure—Epirubicin—thyroid cancer	0.00125	0.00184	CcSEcCtD
Bisoprolol—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.00124	0.00183	CcSEcCtD
Bisoprolol—Osteoarthritis—Epirubicin—thyroid cancer	0.00122	0.00179	CcSEcCtD
Bisoprolol—Hot flush—Doxorubicin—thyroid cancer	0.00121	0.00177	CcSEcCtD
Bisoprolol—Affect lability—Epirubicin—thyroid cancer	0.0012	0.00176	CcSEcCtD
Bisoprolol—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.0012	0.00176	CcSEcCtD
Bisoprolol—Menopausal symptoms—Doxorubicin—thyroid cancer	0.0012	0.00176	CcSEcCtD
Bisoprolol—Hypersensitivity—Sorafenib—thyroid cancer	0.00119	0.00176	CcSEcCtD
Bisoprolol—Purpura—Doxorubicin—thyroid cancer	0.00117	0.00172	CcSEcCtD
Bisoprolol—Asthenia—Sorafenib—thyroid cancer	0.00116	0.00171	CcSEcCtD
Bisoprolol—Cardiac arrest—Epirubicin—thyroid cancer	0.00116	0.0017	CcSEcCtD
Bisoprolol—Cardiac failure—Doxorubicin—thyroid cancer	0.00116	0.0017	CcSEcCtD
Bisoprolol—Hypoglycaemia—Doxorubicin—thyroid cancer	0.00116	0.0017	CcSEcCtD
Bisoprolol—Mood swings—Epirubicin—thyroid cancer	0.00116	0.0017	CcSEcCtD
Bisoprolol—Pruritus—Sorafenib—thyroid cancer	0.00115	0.00169	CcSEcCtD
Bisoprolol—Osteoarthritis—Doxorubicin—thyroid cancer	0.00113	0.00166	CcSEcCtD
Bisoprolol—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00111	0.00164	CcSEcCtD
Bisoprolol—Abdominal pain upper—Epirubicin—thyroid cancer	0.00111	0.00164	CcSEcCtD
Bisoprolol—Affect lability—Doxorubicin—thyroid cancer	0.00111	0.00163	CcSEcCtD
Bisoprolol—Diarrhoea—Sorafenib—thyroid cancer	0.00111	0.00163	CcSEcCtD
Bisoprolol—Breast disorder—Epirubicin—thyroid cancer	0.0011	0.00162	CcSEcCtD
Bisoprolol—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.0011	0.00161	CcSEcCtD
Bisoprolol—Gastritis—Epirubicin—thyroid cancer	0.00108	0.00159	CcSEcCtD
Bisoprolol—Muscular weakness—Epirubicin—thyroid cancer	0.00108	0.00158	CcSEcCtD
Bisoprolol—Cardiac arrest—Doxorubicin—thyroid cancer	0.00107	0.00158	CcSEcCtD
Bisoprolol—Dizziness—Sorafenib—thyroid cancer	0.00107	0.00158	CcSEcCtD
Bisoprolol—Mood swings—Doxorubicin—thyroid cancer	0.00107	0.00157	CcSEcCtD
Bisoprolol—Asthma—Epirubicin—thyroid cancer	0.00105	0.00155	CcSEcCtD
Bisoprolol—Vomiting—Sorafenib—thyroid cancer	0.00103	0.00152	CcSEcCtD
Bisoprolol—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00103	0.00151	CcSEcCtD
Bisoprolol—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00103	0.00151	CcSEcCtD
Bisoprolol—Rash—Sorafenib—thyroid cancer	0.00102	0.0015	CcSEcCtD
Bisoprolol—Dermatitis—Sorafenib—thyroid cancer	0.00102	0.0015	CcSEcCtD
Bisoprolol—Breast disorder—Doxorubicin—thyroid cancer	0.00102	0.0015	CcSEcCtD
Bisoprolol—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00102	0.00149	CcSEcCtD
Bisoprolol—Headache—Sorafenib—thyroid cancer	0.00102	0.00149	CcSEcCtD
Bisoprolol—Bronchitis—Epirubicin—thyroid cancer	0.00101	0.00149	CcSEcCtD
Bisoprolol—Gastritis—Doxorubicin—thyroid cancer	0.000999	0.00147	CcSEcCtD
Bisoprolol—Muscular weakness—Doxorubicin—thyroid cancer	0.000995	0.00146	CcSEcCtD
Bisoprolol—Asthma—Doxorubicin—thyroid cancer	0.000975	0.00143	CcSEcCtD
Bisoprolol—Nausea—Sorafenib—thyroid cancer	0.000963	0.00142	CcSEcCtD
Bisoprolol—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000962	0.00141	CcSEcCtD
Bisoprolol—Weight increased—Epirubicin—thyroid cancer	0.000959	0.00141	CcSEcCtD
Bisoprolol—Pneumonia—Epirubicin—thyroid cancer	0.000945	0.00139	CcSEcCtD
Bisoprolol—Drowsiness—Epirubicin—thyroid cancer	0.00094	0.00138	CcSEcCtD
Bisoprolol—Bronchitis—Doxorubicin—thyroid cancer	0.000938	0.00138	CcSEcCtD
Bisoprolol—Urinary tract infection—Epirubicin—thyroid cancer	0.000913	0.00134	CcSEcCtD
Bisoprolol—Conjunctivitis—Epirubicin—thyroid cancer	0.000913	0.00134	CcSEcCtD
Bisoprolol—Sweating—Epirubicin—thyroid cancer	0.000901	0.00132	CcSEcCtD
Bisoprolol—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00089	0.00131	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000889	0.00131	CcSEcCtD
Bisoprolol—Weight increased—Doxorubicin—thyroid cancer	0.000887	0.0013	CcSEcCtD
Bisoprolol—Sinusitis—Epirubicin—thyroid cancer	0.000882	0.0013	CcSEcCtD
Bisoprolol—Agranulocytosis—Epirubicin—thyroid cancer	0.000877	0.00129	CcSEcCtD
Bisoprolol—Pneumonia—Doxorubicin—thyroid cancer	0.000875	0.00129	CcSEcCtD
Bisoprolol—Drowsiness—Doxorubicin—thyroid cancer	0.000869	0.00128	CcSEcCtD
Bisoprolol—Bradycardia—Epirubicin—thyroid cancer	0.000859	0.00126	CcSEcCtD
Bisoprolol—Rhinitis—Epirubicin—thyroid cancer	0.000846	0.00124	CcSEcCtD
Bisoprolol—Conjunctivitis—Doxorubicin—thyroid cancer	0.000845	0.00124	CcSEcCtD
Bisoprolol—Urinary tract infection—Doxorubicin—thyroid cancer	0.000845	0.00124	CcSEcCtD
Bisoprolol—Hepatitis—Epirubicin—thyroid cancer	0.000844	0.00124	CcSEcCtD
Bisoprolol—Hypoaesthesia—Epirubicin—thyroid cancer	0.000839	0.00123	CcSEcCtD
Bisoprolol—Pharyngitis—Epirubicin—thyroid cancer	0.000837	0.00123	CcSEcCtD
Bisoprolol—Sweating—Doxorubicin—thyroid cancer	0.000834	0.00123	CcSEcCtD
Bisoprolol—Oedema peripheral—Epirubicin—thyroid cancer	0.000831	0.00122	CcSEcCtD
Bisoprolol—Connective tissue disorder—Epirubicin—thyroid cancer	0.000829	0.00122	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000822	0.00121	CcSEcCtD
Bisoprolol—Sinusitis—Doxorubicin—thyroid cancer	0.000816	0.0012	CcSEcCtD
Bisoprolol—Visual impairment—Epirubicin—thyroid cancer	0.000813	0.0012	CcSEcCtD
Bisoprolol—Agranulocytosis—Doxorubicin—thyroid cancer	0.000811	0.00119	CcSEcCtD
Bisoprolol—Bradycardia—Doxorubicin—thyroid cancer	0.000795	0.00117	CcSEcCtD
Bisoprolol—Eye disorder—Epirubicin—thyroid cancer	0.000788	0.00116	CcSEcCtD
Bisoprolol—Tinnitus—Epirubicin—thyroid cancer	0.000787	0.00116	CcSEcCtD
Bisoprolol—Flushing—Epirubicin—thyroid cancer	0.000783	0.00115	CcSEcCtD
Bisoprolol—Cardiac disorder—Epirubicin—thyroid cancer	0.000783	0.00115	CcSEcCtD
Bisoprolol—Rhinitis—Doxorubicin—thyroid cancer	0.000783	0.00115	CcSEcCtD
Bisoprolol—Hepatitis—Doxorubicin—thyroid cancer	0.000781	0.00115	CcSEcCtD
Bisoprolol—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000777	0.00114	CcSEcCtD
Bisoprolol—Pharyngitis—Doxorubicin—thyroid cancer	0.000775	0.00114	CcSEcCtD
Bisoprolol—Oedema peripheral—Doxorubicin—thyroid cancer	0.000769	0.00113	CcSEcCtD
Bisoprolol—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000767	0.00113	CcSEcCtD
Bisoprolol—Angiopathy—Epirubicin—thyroid cancer	0.000765	0.00113	CcSEcCtD
Bisoprolol—Mediastinal disorder—Epirubicin—thyroid cancer	0.00076	0.00112	CcSEcCtD
Bisoprolol—Arrhythmia—Epirubicin—thyroid cancer	0.000754	0.00111	CcSEcCtD
Bisoprolol—Visual impairment—Doxorubicin—thyroid cancer	0.000752	0.00111	CcSEcCtD
Bisoprolol—Alopecia—Epirubicin—thyroid cancer	0.000745	0.0011	CcSEcCtD
Bisoprolol—Mental disorder—Epirubicin—thyroid cancer	0.000739	0.00109	CcSEcCtD
Bisoprolol—Erythema—Epirubicin—thyroid cancer	0.000734	0.00108	CcSEcCtD
Bisoprolol—Eye disorder—Doxorubicin—thyroid cancer	0.000729	0.00107	CcSEcCtD
Bisoprolol—Tinnitus—Doxorubicin—thyroid cancer	0.000728	0.00107	CcSEcCtD
Bisoprolol—Cardiac disorder—Doxorubicin—thyroid cancer	0.000724	0.00106	CcSEcCtD
Bisoprolol—Flushing—Doxorubicin—thyroid cancer	0.000724	0.00106	CcSEcCtD
Bisoprolol—Dysgeusia—Epirubicin—thyroid cancer	0.000719	0.00106	CcSEcCtD
Bisoprolol—Back pain—Epirubicin—thyroid cancer	0.00071	0.00104	CcSEcCtD
Bisoprolol—Angiopathy—Doxorubicin—thyroid cancer	0.000708	0.00104	CcSEcCtD
Bisoprolol—Muscle spasms—Epirubicin—thyroid cancer	0.000706	0.00104	CcSEcCtD
Bisoprolol—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000703	0.00103	CcSEcCtD
Bisoprolol—Arrhythmia—Doxorubicin—thyroid cancer	0.000697	0.00102	CcSEcCtD
Bisoprolol—Alopecia—Doxorubicin—thyroid cancer	0.00069	0.00101	CcSEcCtD
Bisoprolol—Mental disorder—Doxorubicin—thyroid cancer	0.000684	0.00101	CcSEcCtD
Bisoprolol—Ill-defined disorder—Epirubicin—thyroid cancer	0.000681	0.001	CcSEcCtD
Bisoprolol—Erythema—Doxorubicin—thyroid cancer	0.000679	0.000999	CcSEcCtD
Bisoprolol—Agitation—Epirubicin—thyroid cancer	0.000675	0.000992	CcSEcCtD
Bisoprolol—Dysgeusia—Doxorubicin—thyroid cancer	0.000665	0.000978	CcSEcCtD
Bisoprolol—Malaise—Epirubicin—thyroid cancer	0.000662	0.000973	CcSEcCtD
Bisoprolol—Vertigo—Epirubicin—thyroid cancer	0.00066	0.00097	CcSEcCtD
Bisoprolol—Syncope—Epirubicin—thyroid cancer	0.000659	0.000968	CcSEcCtD
Bisoprolol—Back pain—Doxorubicin—thyroid cancer	0.000657	0.000966	CcSEcCtD
Bisoprolol—Muscle spasms—Doxorubicin—thyroid cancer	0.000653	0.00096	CcSEcCtD
Bisoprolol—Palpitations—Epirubicin—thyroid cancer	0.000649	0.000954	CcSEcCtD
Bisoprolol—Loss of consciousness—Epirubicin—thyroid cancer	0.000645	0.000949	CcSEcCtD
Bisoprolol—Cough—Epirubicin—thyroid cancer	0.000641	0.000942	CcSEcCtD
Bisoprolol—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00063	0.000927	CcSEcCtD
Bisoprolol—Arthralgia—Epirubicin—thyroid cancer	0.000625	0.000919	CcSEcCtD
Bisoprolol—Chest pain—Epirubicin—thyroid cancer	0.000625	0.000919	CcSEcCtD
Bisoprolol—Myalgia—Epirubicin—thyroid cancer	0.000625	0.000919	CcSEcCtD
Bisoprolol—Agitation—Doxorubicin—thyroid cancer	0.000624	0.000918	CcSEcCtD
Bisoprolol—Anxiety—Epirubicin—thyroid cancer	0.000623	0.000916	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000621	0.000913	CcSEcCtD
Bisoprolol—Discomfort—Epirubicin—thyroid cancer	0.000618	0.000908	CcSEcCtD
Bisoprolol—Malaise—Doxorubicin—thyroid cancer	0.000613	0.000901	CcSEcCtD
Bisoprolol—Dry mouth—Epirubicin—thyroid cancer	0.000611	0.000899	CcSEcCtD
Bisoprolol—Vertigo—Doxorubicin—thyroid cancer	0.00061	0.000897	CcSEcCtD
Bisoprolol—Syncope—Doxorubicin—thyroid cancer	0.000609	0.000896	CcSEcCtD
Bisoprolol—Confusional state—Epirubicin—thyroid cancer	0.000604	0.000888	CcSEcCtD
Bisoprolol—Palpitations—Doxorubicin—thyroid cancer	0.0006	0.000883	CcSEcCtD
Bisoprolol—Oedema—Epirubicin—thyroid cancer	0.000599	0.000881	CcSEcCtD
Bisoprolol—Loss of consciousness—Doxorubicin—thyroid cancer	0.000597	0.000878	CcSEcCtD
Bisoprolol—Infection—Epirubicin—thyroid cancer	0.000595	0.000875	CcSEcCtD
Bisoprolol—Cough—Doxorubicin—thyroid cancer	0.000593	0.000872	CcSEcCtD
Bisoprolol—Shock—Epirubicin—thyroid cancer	0.00059	0.000867	CcSEcCtD
Bisoprolol—Nervous system disorder—Epirubicin—thyroid cancer	0.000588	0.000864	CcSEcCtD
Bisoprolol—Thrombocytopenia—Epirubicin—thyroid cancer	0.000587	0.000863	CcSEcCtD
Bisoprolol—Tachycardia—Epirubicin—thyroid cancer	0.000585	0.00086	CcSEcCtD
Bisoprolol—Skin disorder—Epirubicin—thyroid cancer	0.000582	0.000856	CcSEcCtD
Bisoprolol—Hyperhidrosis—Epirubicin—thyroid cancer	0.000579	0.000852	CcSEcCtD
Bisoprolol—Arthralgia—Doxorubicin—thyroid cancer	0.000578	0.00085	CcSEcCtD
Bisoprolol—Myalgia—Doxorubicin—thyroid cancer	0.000578	0.00085	CcSEcCtD
Bisoprolol—Chest pain—Doxorubicin—thyroid cancer	0.000578	0.00085	CcSEcCtD
Bisoprolol—Anxiety—Doxorubicin—thyroid cancer	0.000576	0.000847	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000574	0.000844	CcSEcCtD
Bisoprolol—Discomfort—Doxorubicin—thyroid cancer	0.000572	0.00084	CcSEcCtD
Bisoprolol—Dry mouth—Doxorubicin—thyroid cancer	0.000566	0.000832	CcSEcCtD
Bisoprolol—Hypotension—Epirubicin—thyroid cancer	0.00056	0.000823	CcSEcCtD
Bisoprolol—Confusional state—Doxorubicin—thyroid cancer	0.000559	0.000822	CcSEcCtD
Bisoprolol—Oedema—Doxorubicin—thyroid cancer	0.000555	0.000815	CcSEcCtD
Bisoprolol—Infection—Doxorubicin—thyroid cancer	0.000551	0.00081	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000546	0.000803	CcSEcCtD
Bisoprolol—Shock—Doxorubicin—thyroid cancer	0.000546	0.000802	CcSEcCtD
Bisoprolol—Nervous system disorder—Doxorubicin—thyroid cancer	0.000544	0.000799	CcSEcCtD
Bisoprolol—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000543	0.000798	CcSEcCtD
Bisoprolol—Insomnia—Epirubicin—thyroid cancer	0.000542	0.000797	CcSEcCtD
Bisoprolol—Tachycardia—Doxorubicin—thyroid cancer	0.000541	0.000796	CcSEcCtD
Bisoprolol—Skin disorder—Doxorubicin—thyroid cancer	0.000539	0.000792	CcSEcCtD
Bisoprolol—Paraesthesia—Epirubicin—thyroid cancer	0.000538	0.000791	CcSEcCtD
Bisoprolol—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000536	0.000788	CcSEcCtD
Bisoprolol—Dyspnoea—Epirubicin—thyroid cancer	0.000534	0.000785	CcSEcCtD
Bisoprolol—Somnolence—Epirubicin—thyroid cancer	0.000533	0.000783	CcSEcCtD
Bisoprolol—Dyspepsia—Epirubicin—thyroid cancer	0.000528	0.000775	CcSEcCtD
Bisoprolol—Hypotension—Doxorubicin—thyroid cancer	0.000518	0.000762	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000517	0.000761	CcSEcCtD
Bisoprolol—Fatigue—Epirubicin—thyroid cancer	0.000517	0.00076	CcSEcCtD
Bisoprolol—Pain—Epirubicin—thyroid cancer	0.000513	0.000753	CcSEcCtD
Bisoprolol—Constipation—Epirubicin—thyroid cancer	0.000513	0.000753	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000505	0.000743	CcSEcCtD
Bisoprolol—Insomnia—Doxorubicin—thyroid cancer	0.000502	0.000737	CcSEcCtD
Bisoprolol—Paraesthesia—Doxorubicin—thyroid cancer	0.000498	0.000732	CcSEcCtD
Bisoprolol—Dyspnoea—Doxorubicin—thyroid cancer	0.000494	0.000727	CcSEcCtD
Bisoprolol—Feeling abnormal—Epirubicin—thyroid cancer	0.000494	0.000726	CcSEcCtD
Bisoprolol—Somnolence—Doxorubicin—thyroid cancer	0.000493	0.000725	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00049	0.00072	CcSEcCtD
Bisoprolol—Dyspepsia—Doxorubicin—thyroid cancer	0.000488	0.000718	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000479	0.000704	CcSEcCtD
Bisoprolol—Fatigue—Doxorubicin—thyroid cancer	0.000478	0.000703	CcSEcCtD
Bisoprolol—Urticaria—Epirubicin—thyroid cancer	0.000476	0.0007	CcSEcCtD
Bisoprolol—Pain—Doxorubicin—thyroid cancer	0.000474	0.000697	CcSEcCtD
Bisoprolol—Constipation—Doxorubicin—thyroid cancer	0.000474	0.000697	CcSEcCtD
Bisoprolol—Abdominal pain—Epirubicin—thyroid cancer	0.000474	0.000696	CcSEcCtD
Bisoprolol—Body temperature increased—Epirubicin—thyroid cancer	0.000474	0.000696	CcSEcCtD
Bisoprolol—Feeling abnormal—Doxorubicin—thyroid cancer	0.000457	0.000672	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000453	0.000667	CcSEcCtD
Bisoprolol—Hypersensitivity—Epirubicin—thyroid cancer	0.000442	0.000649	CcSEcCtD
Bisoprolol—Urticaria—Doxorubicin—thyroid cancer	0.000441	0.000648	CcSEcCtD
Bisoprolol—Abdominal pain—Doxorubicin—thyroid cancer	0.000438	0.000644	CcSEcCtD
Bisoprolol—Body temperature increased—Doxorubicin—thyroid cancer	0.000438	0.000644	CcSEcCtD
Bisoprolol—Asthenia—Epirubicin—thyroid cancer	0.00043	0.000632	CcSEcCtD
Bisoprolol—Pruritus—Epirubicin—thyroid cancer	0.000424	0.000623	CcSEcCtD
Bisoprolol—Diarrhoea—Epirubicin—thyroid cancer	0.00041	0.000603	CcSEcCtD
Bisoprolol—Hypersensitivity—Doxorubicin—thyroid cancer	0.000409	0.000601	CcSEcCtD
Bisoprolol—Asthenia—Doxorubicin—thyroid cancer	0.000398	0.000585	CcSEcCtD
Bisoprolol—Dizziness—Epirubicin—thyroid cancer	0.000396	0.000583	CcSEcCtD
Bisoprolol—Pruritus—Doxorubicin—thyroid cancer	0.000392	0.000577	CcSEcCtD
Bisoprolol—Vomiting—Epirubicin—thyroid cancer	0.000381	0.00056	CcSEcCtD
Bisoprolol—Diarrhoea—Doxorubicin—thyroid cancer	0.000379	0.000558	CcSEcCtD
Bisoprolol—Rash—Epirubicin—thyroid cancer	0.000378	0.000555	CcSEcCtD
Bisoprolol—Dermatitis—Epirubicin—thyroid cancer	0.000378	0.000555	CcSEcCtD
Bisoprolol—Headache—Epirubicin—thyroid cancer	0.000375	0.000552	CcSEcCtD
Bisoprolol—Dizziness—Doxorubicin—thyroid cancer	0.000367	0.000539	CcSEcCtD
Bisoprolol—Nausea—Epirubicin—thyroid cancer	0.000356	0.000523	CcSEcCtD
Bisoprolol—Vomiting—Doxorubicin—thyroid cancer	0.000353	0.000518	CcSEcCtD
Bisoprolol—Rash—Doxorubicin—thyroid cancer	0.00035	0.000514	CcSEcCtD
Bisoprolol—Dermatitis—Doxorubicin—thyroid cancer	0.000349	0.000513	CcSEcCtD
Bisoprolol—Headache—Doxorubicin—thyroid cancer	0.000347	0.000511	CcSEcCtD
Bisoprolol—Nausea—Doxorubicin—thyroid cancer	0.000329	0.000484	CcSEcCtD
